Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
63.6%
% of PJP's 22 holdings also in XPH
35.0%
% of XPH's 40 holdings also in PJP
Overlap by Weight
Sector Drift (PJP minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PJP |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
MERCK & CO. INC. | 5.9% | 4.8% | 4.8% |
|
ELI LILLY & CO | 6.1% | 4.8% | 4.8% |
|
PFIZER INC | 5.7% | 4.6% | 4.6% |
|
JOHNSON & JOHNSON | 5.7% | 4.5% | 4.5% |
|
CORCEPT THERAPEUTICS INC | 4.1% | 3.6% | 3.6% |
Position Highlights (Non-Overlapping Exposures)
PJP Overweight Relative to XPH
|
GERON CORP | 6.2% |
|
REGENERON PHARMACEUTICALS | 5.8% |
|
ABBVIE INC | 5.7% |
|
ABBOTT LABORATORIES | 5.6% |
|
AMGEN INC | 5.6% |
|
UNITED THERAPEUTICS CORP | 4.0% |
|
BIOSANTE PHARMACEUTICALS INC | 3.6% |
|
GILEAD SCIENCES INC | 3.5% |
|
SUPERNUS PHARMACEUTICALS INC | 3.4% |
|
BIOGEN IDEC INC | 3.4% |
PJP Underweight Relative to XPH
|
INTRA-CELLULAR THERAPIES INC | -4.7% |
|
CATALENT INC | -4.7% |
|
AXSOME THERAPEUTICS, INC. | -4.6% |
|
ORGANON & CO. | -4.5% |
|
VIATRIS, INC. | -4.5% |
|
ROYALTY PHARMA PLC CLASS A | -4.5% |
|
BRISTOL-MYERS SQUIBB CO | -4.4% |
|
ELANCO ANIMAL HEALTH, INC. | -4.4% |
|
ZOETIS INC | -4.2% |
|
ARVINAS, INC. | -2.8% |